Absence of Disproportionately Enlarged Subarachnoid Space Hydrocephalus, a Sharp Callosal Angle, or Other Morphologic MRI Markers Should Not Be Used to Exclude Patients with Idiopathic Normal Pressure Hydrocephalus from Shunt Surgery

S. Agerskov; M. Wallin; P. Hellström; D. Ziegelitz; C. Wikkelsö; M. Tullberg

doi:10.3174/ajnr.A5910

Abstract

BACKGROUND AND PURPOSE: Several studies have evaluated the use of MR imaging markers for the prediction of outcome after shunt surgery in idiopathic normal pressure hydrocephalus with conflicting results. Our aim was to investigate the predictive value of a number of earlier proposed morphologic MR imaging markers in a large group of patients with idiopathic normal pressure hydrocephalus.

MATERIALS AND METHODS: One hundred sixty-eight patients (mean age, 70 ± 9.3 years) with idiopathic normal pressure hydrocephalus, subjected to standardized quantification of clinical symptoms before and after shunt surgery, were included in the study. Outcome was calculated using a composite score. Preoperative T1, FLAIR, and flow-sensitive images were analyzed regarding the presence of 13 different morphologic MR imaging markers.

RESULTS: The median Evans index was 0.41 (interquartile range, 0.37–0.44). All patients had an aqueductal flow void sign present and white matter hyperintensities. The median callosal angle was 68.8° (interquartile range, 57.7°–80.8°). Dilated Sylvian fissures were found in 69%; focally dilated sulci, in 25%; and widening of the interhemispheric fissure, in 55%. Obliteration of the sulci at the convexity was found in 36%, and 36% of patients were characterized as having disproportionately enlarged subarachnoid space hydrocephalus. Sixty-eight percent of patients improved after surgery. None of the investigated MR imaging markers were significant predictors of improvement after shunt surgery.

CONCLUSIONS: Disproportionately enlarged subarachnoid space hydrocephalus, a small callosal angle, and the other MR imaging markers evaluated in this study should not be used to exclude patients from shunt surgery. These markers, though they may be indicative of idiopathic normal pressure hydrocephalus, do not seem to be a part of the mechanisms connected to the reversibility of the syndrome.

ABBREVIATIONS:

DESH: disproportionately enlarged subarachnoid space hydrocephalus
EI: Evans index
iNPH: idiopathic normal pressure hydrocephalus

Idiopathic normal pressure hydrocephalus (iNPH) is a syndrome of gait and balance disturbances, cognitive dysfunction, and urinary incontinence seen predominantly in the elderly population.^{1⇓⇓⇓–5} Enlarged ventricles on CT or MR imaging are required for the diagnosis, and different radiologic evaluation techniques have been used to increase the diagnostic and predictive accuracy ever since its first description by Adams et al.⁶ Today, MR imaging is considered the standard radiologic method, and MR imaging–based criteria for diagnosing the condition are incorporated in the international and Japanese diagnostic guidelines.^1,2

In the international guidelines, ventriculomegaly with an Evans index (EI) of >0.3 in combination with at least 1 of 4 supportive findings is required for the diagnosis of probable iNPH.² The Japanese criteria instead emphasize the finding of disproportionately enlarged subarachnoid space hydrocephalus (DESH), requiring it for the diagnosis of probable iNPH if no Tap-Test or CSF drainage test is performed.¹

The connection between radiologic findings and symptoms in iNPH has also recently been reinforced with the use of a composite scale score including morphologic CT findings in patients with iNPH.⁷

The use of morphologic MR imaging markers for selecting appropriate shunt surgery candidates has been investigated, but results vary; the use of these markers for predictive purposes is still disputed.^{8⇓⇓⇓–12} DESH¹³ has won support as a prognostic marker,¹⁴ most recently by Shinoda et al,¹⁵ who developed a 10-point grading scale to aid in patient selection for surgery. Virhammar et al^8,16 reported that the presence of DESH, a narrow callosal angle (<63°), and dilation of the temporal horns were predictors of good surgical outcome.

The use of morphologic MR imaging markers for predicting outcome after shunt surgery in patients with iNPH requires further investigation. Hence, the aim of this study was to investigate the association between 13 morphologic MR imaging markers and postoperative outcome in a large consecutive cohort of patients with iNPH subjected to a detailed clinical evaluation.

Materials and Methods

One-hundred sixty-eight patients consecutively diagnosed with iNPH in accordance with the international guidelines² who underwent shunt surgery between 2006 and 2013 were included in the study. Patients were included if they had a complete preoperative MR imaging scan including volumetric T1, FLAIR, and flow-sensitive T2 sequences. If substantial movement artifacts were present on any of the sequences, the patient was excluded. Demographic data of the patient group are shown in Table 1.

View this table:

Table 1:

Demographic data of 168 patients with iNPH

Clinical Evaluation

All patients underwent detailed clinical examinations by a neurologist and a physiotherapist preoperatively and 3–6 months postoperatively following standardized protocols.⁵ To evaluate outcome after shunt surgery, we created a composite score incorporating 4 continuous measures based on 2 gait tests and 2 cognitive tests (the Timed 10-Meter Walk Test¹⁷; the Timed Up and Go Test¹⁸; the Identical Forms Test, measuring perceptual speed and accuracy; and the Bingley Memory Test¹⁹). Each score was standardized into a 0–100 scale with 0 representing the worst possible performance and 100 equaling the mean performance of healthy individuals at 70 years of age.^4,17,20 The composite score was calculated using the mean value of the 4 included tests, and the difference between the pre- and postoperative score constituted the outcome for each patient. Patients were classified as improved if their score increased by ≥5 points.^4,5 All shunts were functioning at the time of the postoperative clinical evaluation.

Imaging

All preoperative MR imaging scans were performed using a 1.5T Intera (Philips Healthcare, Best, the Netherlands) or a 1.5T Achieva dStream (Philips Healthcare) scanner. The imaging sequences were reformatted and analyzed using an Advantage Workstation 2.0 (GE Healthcare, Milwaukee, Wisconsin). The imaging protocol consisted of the following: 1) a sagittal T1-weighted volume sequence with TR/TE = 25/4.6 ms, flip angle = 30°, FOV = 260 × 260 × 190 mm³, matrix = 260 × 259, and 380 overcontiguous 1-mm slices; 2) a transaxial FLAIR sequence with TR/TE = 9000/100 ms, inversion recovery delay = 2500 ms, FOV = 230 × 230 × 230 mm³, matrix = 192 × 192, 44 sections, 3-mm slice thickness, and no gap; 3) a flow-sensitive sagittal TSE sequence with TR/TE = 10,238/300 ms, FOV = 230 × 230 × 38 mm³, matrix = 384 × 284, thirteen sections, 2-mm slice thickness, and 1-mm gap; and 4) an aqueduct-centered turbo field echo sequence with TR/TE= 7.7/3.8 ms, flip angle = 60°, FOV = 150 × 150 × 15 mm³, matrix = 256 × 256 with 75 overcontiguous 0.2-mm slices.

On the T1-weighted volume sequences, a line connecting the anterior and posterior commissures was defined (ie, the anterior/posterior commissure plane).^8,16,21 The T1-weighted 3D volumes were then reformatted generating coronal images perpendicular to and transaxial images parallel to the anterior/posterior commissure plane. All reformatted T1-weighted volume sequences had voxel sizes of 1 × 1 × 1 mm and were used with the FLAIR, TSE, and turbo field echo sequences in the image analyses.

In total, 13 imaging markers were analyzed (Figure).

FIGURE.

Morphologic MR imaging markers analyzed in 168 patients with iNPH preoperatively. A, Evans index. B, Maximum width of the temporal horns. C, Callosal angle. D, Maximum width of the third ventricle. E, Maximum anteroposterior diameter of the fourth ventricle. F, Obliteration of sulci at the vertex. G, Transport of sulci on transaxial and coronal images (left-right). H, Width of the Sylvian fissures graded 0 to 1–2 (left-right). I, Width of the interhemispheric fissure graded 0 to 1–2 (left-right). J, Flow void sign graded 1 to 2–3 (left-right, 0 not shown in the figure).

The EI was measured on transaxial T1-weighted images as the index between the maximum diameter of the frontal horns and the maximum inner skull diameter in the slice above the foramen of Monro (Fig A). Then, the maximum diameter of the temporal horns was recorded bilaterally (Fig B). The callosal angle was analyzed on coronal T1 images at the level of the posterior commissure (Fig C).¹⁶

Coronal T1 images were also used to measure the widest diameter of the third ventricle between the anterior and posterior commissures (Fig D). On sagittal T1 slices, the widest anteroposterior midline diameter of the fourth ventricle was determined along a line perpendicular to the posterior border of the brain stem (Fig E).

Obliteration of the high-convexity sulci was assessed on transaxial T1 images and graded as obliterated if no sulci were distinguishable on the 10 most cranial slices covering the vertex (Fig F).

The presence of focally enlarged (transport) sulci was analyzed on transaxial and coronal T1 series. The sulci were only determined as focally widened if there were no signs of general cortical atrophy, the sulcal widening was asymmetric, and the affected sulci lacked connection with the Sylvian fissure. The number of focally widened sulci was recorded (Fig G).

Dilation of the Sylvian fissures was measured on coronal T1 images using an ordinal scale (Fig H).^16,22 Widening of the anterior part of the interhemispheric fissure was estimated on transaxial T1 images using a 3-step ordinal scale (Fig I). The flow void phenomenon in the cerebral aqueduct and fourth ventricle (flow void sign) was evaluated and graded using the ordinal scale developed by Algin et al²³ and later modified by Virhammar et al (Fig J).⁸ Periventricular and deep white matter hyperintensities were analyzed on transaxial FLAIR series using the scale developed by Fazekas et al.²⁴

DESH was considered present if patients showed signs of Sylvian fissure dilation (ordinal rating 1 or 2) in conjunction with obliterated sulci at the high convexity.

Analyses were performed in a retrospective manner with investigators blinded to the patients' clinical data. To ensure reproducibility, 2 authors (S.A., M.W.) analyzed all variables independently in 10 randomly selected patients and calculated interrater reliability. In cases in which discrepancies occurred, the variables were redefined and re-evaluated until an interrater reliability of >0.7 was achieved. The development of the image-analysis protocol was supervised by an experienced neuroradiologist (D.Z.) who also assisted in the refinement of MR imaging markers as required until the interrater reliability ratings were sufficient. In addition, 20% of patient scans were randomly selected and re-evaluated by one of the authors (S.A.) to calculate the test-retest reliability, which was >0.8 for all variables.

Statistics

All statistical tests were performed using nonparametric procedures. Differences in distributions among binary variables were tested using the McNemar test. Tests of differences between groups for ordinal and interval data were performed using the Wilcoxon rank sum test. Correlations were tested using Spearman rank correlations. Associations between outcome and analyzed MR imaging variables were assessed using logistic regression models with results presented as odds ratios with 95% confidence intervals. Interrater and test-retest reliability was calculated using intraclass correlation coefficients for continuous variables and the weighted/unweighted Cohen κ for ordinal and nominal variables, respectively. Statistical significance was P < .05. All calculations were performed in SPSS, Version 24.0, released in 2014 (IBM, Armonk, New York).

Ethical Considerations

The data collection was approved by the Ethics Committee for Medical Research at Gothenburg University, with written informed consent obtained from all participants or close relatives.

Results

Surgical Outcome

Sixty-eight percent (n = 115) of the patients improved after shunt surgery, 23% (n = 39) were unchanged, and conditions of 8% (n = 14) deteriorated. Improvement was most pronounced in the gait domain (Table 2).

View this table:

Table 2:

Pre- and postoperative gait, cognitive, and total scores in 168 patients with iNPH

Preoperative MR Imaging Findings and Outcome

All patients had an EI of >0.3, a present flow void sign, white matter hyperintensities, and a callosal angle of <90° (Table 3). Dilation of the Sylvian fissures was found in 72%, while focal dilation of the supra-Sylvian sulci and obliteration of sulci at the high convexity were more uncommon (28%–36%). Thirty-nine percent had a callosal angle of <63°(responders, 39%; nonresponders, 38%; P = not significant). There were no significant differences between responders and nonresponders in the distribution of any of the morphologic MR imaging markers or in the prevalence of periventricular and deep white matter changes. Furthermore, the severity of white matter changes did not have any effect on postoperative outcome.

View this table:

Table 3:

Preoperative morphologic MRI markers in 168 patients with iNPH

In the logistic regression models adjusted for age and sex, no MR imaging marker was significantly associated with postoperative improvement, neither for the total score nor for any of the subdomain scores.

Correlations with Clinical Symptoms

A few measures were significantly correlated with preoperative clinical symptoms. However, the correlations were all weak (ie, <.30) (Table 4).

View this table:

Table 4:

Correlation coefficients between clinical symptom severity and preoperative MRI findings in 168 patients with iNPH

Discussion

In this study of 168 patients with iNPH, we analyzed a number of proposed MR imaging markers for the prediction of outcome after shunt surgery. We could not show significant associations between any of the analyzed MR imaging markers and postoperative improvement, nor were there significant differences in the presence of proposed imaging markers between improved and nonimproved patients. Specifically, a small callosal angle or the finding of DESH was not associated with a favorable outcome.

The lack of correlation between morphologic MR imaging markers and postoperative improvement corroborates some earlier studies^9,12,25 and contradicts other publications that have reported significant associations between postoperative improvement and the presence of a narrow callosal angle,¹⁶ the DESH phenomenon,^15,16 and dilation of the temporal horns.⁸

A possible explanation for the different results regarding the predictive value of morphologic imaging markers reported here compared with many earlier studies could be the selection of patients. We based the iNPH diagnosis and decision to perform shunt surgery on clinical and radiologic criteria, and only in patients in whom the outcome of shunt surgery was considered uncertain was the CSF Tap-Test or lumbar infusion test used as a supplementary test. Lumbar puncture was performed for intracranial pressure measurement and exclusion of other disorders. Furthermore, with the exception of the EI, none of the imaging markers were specifically required for diagnosis. Diagnostic criteria requiring the presence of DESH, a positive response to CSF drainage, or an increased resistance to CSF outflow such as the Japanese guidelines,¹ entail a possible selection bias in which patients who would potentially improve after shunt surgery were excluded from studies. We believe that the inclusion of patients with iNPH in our study is more general with less selection bias compared with many earlier studies, which could explain differences in results reported. Overall, we consider the patient sample representative, and the results reported here are robust. Moreover, our results are in agreement with those of Craven et al¹²; and in a recent report by Benedetto et al²⁶ using a CT-based method to assess DESH, there were no differences between patients who improved and those who did not improve after shunt surgery.

Another possible cause of the contradictory results in some earlier studies might be the use of different outcome measures. In our study, the aim was to use a sensitive outcome measure similar to the iNPH scale designed by Hellström et al⁴ in order to base our calculations on improvements in continuous variables that are norm-based and thus reproducible. Many of the previous studies have used the modified Rankin Scale, which was developed for use in patients with stroke and does not measure symptom severity in iNPH but instead provides a general measure of disability.²⁷ Other groups have applied outcome scales based on ordinal or nominal ratings,^8,10,15 making a direct comparison with the results presented here more difficult. To maximize the sensitivity and validity of results, one should use quantitative outcome measures if possible.⁴ Using outcome measurements that are blunt or potentially not measuring an actual improvement of hydrocephalic symptoms (such as the modified Rankin Scale) increases the risk of misjudging proposed imaging markers and their use as predictors of postoperative outcome.

The prevalence of DESH in this study is lower in comparison with previous publications.^8,13,28 This outcome might be because in accordance with the international diagnostic guidelines, the components of the DESH phenomenon were not part of the diagnostic criteria for the evaluated iNPH group. Furthermore, we graded sulcal compression at the vertex as obliterated or not, meaning that patients who did not show complete sulcal obliteration but still had some degree of compression in conjunction with Sylvian dilation were graded as not having DESH. However, DESH prevalence figures in patients with iNPH of around 30% have previously been reported,¹² and the same authors did not find any support for DESH as a predictive factor for shunt responsiveness, confirming our results.

While DESH is a common finding in patients with iNPH and can aid in diagnosing the disorder, this study implies that it should be used neither as an obligatory diagnostic finding nor as a predictive marker, given the risk of excluding patients from shunt surgery who might benefit from the procedure.

All patients in our study presented with an EI of >0.3, in agreement with the international guidelines.² In addition, the ventriculomegaly also involved the third and fourth ventricles in most patients, corroborating previous findings.⁹ The enlargement of the third and fourth ventricles also correlated significantly, albeit weakly, with the gait symptom score. Although these findings could not significantly predict good postoperative outcome, they are still important to consider from a pathophysiologic aspect. Infratentorial periventricular structures might be involved in the development of clinical symptoms.^5,29,30

All patients presented with white matter changes on preoperative MR imaging. The severity of these changes did not differ significantly between shunt responders and nonresponders in this study; this result corroborates previously published work^8,31 and reinforces the theory that the extent of white matter damage should not exclude patients from shunt surgery.

Our findings of only weak correlations between ventricular dilation or white matter changes on the one hand and symptom severity on the other differ markedly from a recent study reporting an association between 8 CT-based imaging markers and the severity of clinical symptoms.⁷ The cited study used the iNPH grading scale,⁴ and the statistical analysis was performed using linear regression modeling, which we were unable to reproduce given the absence of a linear relationship between our dependent and independent variables and non-normal data distribution.

Our findings support the view that clinical improvement in iNPH after shunt surgery is mainly attributed to increased metabolism and extracellular fluid flow in predominantly periventricular regions of the brain and not morphologic changes as measured on structural MR imaging. Support for this notion comes from imaging studies of perfusion^{32⇓⇓–35} and diffusion^29,36 and CSF biomarker studies^37,38 as well as a recent study indicating reduced glymphatic clearance in patients with iNPH.³⁹

The results reported here imply that morphologic MR imaging markers only correlate with symptom severity in a limited way and cannot predict postoperative outcome. To find reliable markers for selecting appropriate candidates for shunt surgery, focus should be turned to the use of higher order MR imaging analyses, such as diffusion- and perfusion-based techniques as well as combinations of MR imaging and biochemical methods. Further studies are needed in this area.

Strengths and Weaknesses

The strengths of this study are the large consecutively included patient population, a prospective data collection, and the detailed assessment of clinical outcome after shunt surgery. We also realigned all scans before the subsequent analysis, thus minimizing the effects of possible misalignment. In addition, with the exception of the EI, the analysis of all variables was performed after the diagnosis of iNPH was made, thus reducing the risk of selection bias.

The main limitations are the retrospective image analysis and the fact that a group of patients diagnosed before 2006 had to be excluded because they lacked MR imaging scans that fulfilled our inclusion criteria. The excluded patients did not differ in any demographic data nor in our outcome score compared with our study population. In all, we consider the evaluated patient sample and the results reported here to be representative.

Conclusions

DESH, a small callosal angle, and the other MR imaging markers evaluated in this study should not be used to exclude patients from shunt surgery. These markers, though they may be indicative of iNPH, do not seem to be a part of the mechanisms connected to the reversibility of the syndrome.

Footnotes

Disclosures: Simon Agerskov—RELATED: Grant: Rune and Ulla Amlöv Foundation, Edit Jacobson Foundation, Gothenburg Foundation for Neurological Research. Per Hellström—UNRELATED: Employment: Clinical Neuropsychologist at Sahlgrenska University Hospital. Carsten Wikkelsö—UNRELATED: Board Membership: Associate Editor of Acta Neurologica Scandinavica.
This work was supported by grants from the Edit Jacobson Foundation, the Rune and Ulla Almlövs Foundation for Neurological Research, and the Gothenburg Foundation for Neurological Research.

References

1.↵
2. Mori E,
3. Ishikawa M,
4. Kato T, et al
; Japanese Society of Normal Pressure Hydrocephalus. Guidelines for management of idiopathic normal pressure hydrocephalus: second edition. Neurol Med Chir (Tokyo) 2012;52:775–809 doi:10.2176/nmc.52.775 pmid:23183074
CrossRef PubMed
2.↵
2. Relkin N,
3. Marmarou A,
4. Klinge P, et al
. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery 2005;57(3 Suppl):S4–16; discussion ii-v pmid:16160425
CrossRef PubMed
3.↵
2. Blomsterwall E,
3. Svantesson U,
4. Carlsson U, et al
. Postural disturbance in patients with normal pressure hydrocephalus. Acta Neurol Scand 2000;102:284–91 doi:10.1034/j.1600-0404.2000.102005284.x pmid:11083504
CrossRef PubMed
4.↵
2. Hellström P,
3. Klinge P,
4. Tans J, et al
. A new scale for assessment of severity and outcome in iNPH. Acta Neurol Scand 2012;126:229–37 doi:10.1111/j.1600-0404.2012.01677.x pmid:22587624
CrossRef PubMed
5.↵
2. Agerskov S,
3. Hellström P,
4. Andrén K, et al
. The phenotype of idiopathic normal pressure hydrocephalus: a single center study of 429 patients. J Neurol Sci 2018;391:54–60 doi:10.1016/j.jns.2018.05.022 pmid:30103972
CrossRef PubMed
6.↵
2. Adams RD,
3. Fisher CM,
4. Hakim S, et al
. Symptomatic occult hydrocephalus with normal cerebrospinal-fluid pressure: a treatable syndrome. N Engl J Med 1965;273:117–26 doi:10.1056/NEJM196507152730301 pmid:14303656
CrossRef PubMed
7.↵
2. Kockum K,
3. Lilja-Lund O,
4. Larsson EM, et al
. The idiopathic normal-pressure hydrocephalus Radscale: a radiological scale for structured evaluation. Eur J Neurol 2018;25:569–76 doi:10.1111/ene.13555 pmid:29281156
CrossRef PubMed
8.↵
2. Virhammar J,
3. Laurell K,
4. Cesarini KG, et al
. Preoperative prognostic value of MRI findings in 108 patients with idiopathic normal pressure hydrocephalus. AJNR Am J Neuroradiol 2014;35:2311–18 doi:10.3174/ajnr.A4046 pmid:25012669
Abstract/FREE Full Text
9.↵
2. Wikkelsö C,
3. Andersson H,
4. Blomstrand C, et al
. Computed tomography of the brain in the diagnosis of and prognosis in normal pressure hydrocephalus. Neuroradiology 1989;31:160–65 doi:10.1007/BF00698846 pmid:2747894
CrossRef PubMed
10.↵
2. Kazui H,
3. Mori E,
4. Ohkawa S, et al
. Predictors of the disappearance of triad symptoms in patients with idiopathic normal pressure hydrocephalus after shunt surgery. J Neurol Sci 2013;328:64–69 doi:10.1016/j.jns.2013.02.020 pmid:23510566
CrossRef PubMed
11.↵
2. Halperin JJ,
3. Kurlan R,
4. Schwalb JM, et al
. Practice guideline: idiopathic normal pressure hydrocephalus—response to shunting and predictors of response: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 2015;85:2063–71 doi:10.1212/WNL.0000000000002193 pmid:26644048
Abstract/FREE Full Text
12.↵
2. Craven CL,
3. Toma AK,
4. Mostafa T, et al
. The predictive value of DESH for shunt responsiveness in idiopathic normal pressure hydrocephalus. J Clin Neurosci 2016;34:294–98 doi:10.1016/j.jocn.2016.09.004 pmid:27692614
CrossRef PubMed
13.↵
2. Hashimoto M,
3. Ishikawa M,
4. Mori E, et al
; Study of INPH on neurological improvement (SINPHONI). Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study. Cerebrospinal Fluid Res 2010;7:18 doi:10.1186/1743-8454-7-18 pmid:21040519
CrossRef PubMed
14.↵
2. Garcia-Armengol R,
3. Domenech S,
4. Botella-Campos C, et al
. Comparison of elevated intracranial pressure pulse amplitude and disproportionately enlarged subarachnoid space (DESH) for prediction of surgical results in suspected idiopathic normal pressure hydrocephalus. Acta Neurochir (Wien) 2016;158:2207–13 doi:10.1007/s00701-016-2858-5 pmid:27349896
CrossRef PubMed
15.↵
2. Shinoda N,
3. Hirai O,
4. Hori S, et al
. Utility of MRI-based disproportionately enlarged subarachnoid space hydrocephalus scoring for predicting prognosis after surgery for idiopathic normal pressure hydrocephalus: clinical research. J Neurosurg 2017;127:1436–42 doi:10.3171/2016.9.JNS161080 pmid:28156249
CrossRef PubMed
16.↵
2. Virhammar J,
3. Laurell K,
4. Cesarini KG, et al
. The callosal angle measured on MRI as a predictor of outcome in idiopathic normal-pressure hydrocephalus. J Neurosurg 2014;120:178–84 doi:10.3171/2013.8.JNS13575 pmid:24074491
CrossRef PubMed
17.↵
2. Steffen TM,
3. Hacker TA,
4. Mollinger L
. Age- and gender-related test performance in community-dwelling elderly people: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and gait speeds. Phys Ther 2002;82:128–37 doi:10.1093/ptj/82.2.128 pmid:11856064
Abstract/FREE Full Text
18.↵
2. Podsiadlo D,
3. Richardson S
. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991;39:142–48 doi:10.1111/j.1532-5415.1991.tb01616.x pmid:1991946
CrossRef PubMed
19.↵
2. Tullberg M,
3. Rosengren L,
4. Blomsterwall E, et al
. CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus. Neurology 1998;50:1122–27 doi:10.1212/WNL.50.4.1122 pmid:9566405
Abstract/FREE Full Text
20.↵
2. Solana E,
3. Poca MA,
4. Sahuquillo J, et al
. Cognitive and motor improvement after retesting in normal-pressure hydrocephalus: a real change or merely a learning effect? J Neurosurg 2010;112:399–409 doi:10.3171/2009.4.JNS081664 pmid:19480539
CrossRef PubMed
21.↵
2. Ishii K,
3. Kanda T,
4. Harada A, et al
. Clinical impact of the callosal angle in the diagnosis of idiopathic normal pressure hydrocephalus. Eur Radiol 2008;18:2678–83 doi:10.1007/s00330-008-1044-4 pmid:18500524
CrossRef PubMed
22.↵
2. Kitagaki H,
3. Mori E,
4. Ishii K, et al
. CSF spaces in idiopathic normal pressure hydrocephalus: morphology and volumetry. AJNR Am J Neuroradiol 1998;19:1277–84 pmid:9726467
Abstract/FREE Full Text
23.↵
2. Algin O,
3. Hakyemez B,
4. Taskapilioglu O, et al
. Morphologic features and flow void phenomenon in normal pressure hydrocephalus and other dementias: are they really significant? Acad Radiol 2009;16:1373–80 doi:10.1016/j.acra.2009.06.010 pmid:19717316
CrossRef PubMed
24.↵
2. Fazekas F,
3. Chawluk JB,
4. Alavi A, et al
. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351–56 doi:10.2214/ajr.149.2.351 pmid:3496763
CrossRef PubMed
25.↵
2. Virhammar J,
3. Laurell K,
4. Cesarini KG, et al
. Increase in callosal angle and decrease in ventricular volume after shunt surgery in patients with idiopathic normal pressure hydrocephalus. J Neurosurg 2018 Feb 2:1–6. [Epub ahead of print] doi:10.3171/2017.8.JNS17547 pmid:29393749
CrossRef PubMed
26.↵
2. Benedetto N,
3. Gambacciani C,
4. Aquila F, et al
. A new quantitative method to assess disproportionately enlarged subarachnoid space (DESH) in patients with possible idiopathic normal pressure hydrocephalus: the SILVER index. Clin Neurol Neurosurg 2017;158:27–32 doi:10.1016/j.clineuro.2017.04.015 pmid:28448824
CrossRef PubMed
27.↵
2. Wilson JT,
3. Hareendran A,
4. Hendry A, et al
. Reliability of the modified Rankin Scale across multiple raters: benefits of a structured interview. Stroke 2005;36:777–81 doi:10.1161/01.STR.0000157596.13234.95 pmid:15718510
Abstract/FREE Full Text
28.↵
2. Ishikawa M,
3. Oowaki H,
4. Takezawa M, et al
. Disproportionately enlarged subarachnoid space hydrocephalus in idiopathic normal-pressure hydrocephalus and its implication in pathogenesis. Acta Neurochir Suppl 2016;122:287–90 doi:10.1007/978-3-319-22533-3_57 pmid:27165923
CrossRef PubMed
29.↵
2. Jurcoane A,
3. Keil F,
4. Szelenyi A, et al
. Directional diffusion of corticospinal tract supports therapy decisions in idiopathic normal-pressure hydrocephalus. Neuroradiology 2014;56:5–13 doi:10.1007/s00234-013-1289-8 pmid:24158631
CrossRef PubMed
30.↵
2. Lee PH,
3. Yong SW,
4. Ahn YH, et al
. Correlation of midbrain diameter and gait disturbance in patients with idiopathic normal pressure hydrocephalus. J Neurol 2005;252:958–63 doi:10.1007/s00415-005-0791-2 pmid:15834647
CrossRef PubMed
31.↵
2. Tullberg M,
3. Jensen C,
4. Ekholm S, et al
. Normal pressure hydrocephalus: vascular white matter changes on MR images must not exclude patients from shunt surgery. AJNR Am J Neuroradiol 2001;22:1665–73 pmid:11673159
Abstract/FREE Full Text
32.↵
2. Ziegelitz D,
3. Starck G,
4. Kristiansen D, et al
. Cerebral perfusion measured by dynamic susceptibility contrast MRI is reduced in patients with idiopathic normal pressure hydrocephalus. J Magn Reson Imaging 2014;39:1533–42 doi:10.1002/jmri.24292 pmid:24006249
CrossRef PubMed
33.↵
2. Ziegelitz D,
3. Arvidsson J,
4. Hellström P, et al
. In patients with idiopathic normal pressure hydrocephalus postoperative cerebral perfusion changes measured by dynamic susceptibility contrast magnetic resonance imaging correlate with clinical improvement. J Comput Assist Tomogr 2015;39:531–40 doi:10.1097/RCT.0000000000000254 pmid:25974719
CrossRef PubMed
34.↵
2. Tullberg M,
3. Hellström P,
4. Piechnik SK, et al
. Impaired wakefulness is associated with reduced anterior cingulate CBF in patients with normal pressure hydrocephalus. Acta Neurol Scand 2004;110:322–30 doi:10.1111/j.1600-0404.2004.00325.x pmid:15476461
CrossRef PubMed
35.↵
2. Klinge PM,
3. Brooks DJ,
4. Samii A, et al
. Correlates of local cerebral blood flow (CBF) in normal pressure hydrocephalus patients before and after shunting: a retrospective analysis of [(15)O]H(2)O PET-CBF studies in 65 patients. Clin Neurol Neurosurg 2008;110:369–75 doi:10.1016/j.clineuro.2007.12.019 pmid:18262344
CrossRef PubMed
36.↵
2. Tullberg M,
3. Ziegelitz D,
4. Ribbelin S, et al
. White matter diffusion is higher in Binswanger disease than in idiopathic normal pressure hydrocephalus. Acta Neurol Scand 2009;120:226–34 doi:10.1111/j.1600-0404.2009.01165.x pmid:19485951
CrossRef PubMed
37.↵
2. Jeppsson A,
3. Höltta M,
4. Zetterberg H, et al
. Amyloid mis-metabolism in idiopathic normal pressure hydrocephalus. Fluids Barriers CNS 2016;13:13 doi:10.1186/s12987-016-0037-y pmid:27472944
CrossRef PubMed
38.↵
2. Nakajima M,
3. Miyajima M,
4. Ogino I, et al
. Cerebrospinal fluid biomarkers for prognosis of long-term cognitive treatment outcomes in patients with idiopathic normal pressure hydrocephalus. J Neurol Sci 2015;357:88–95 doi:10.1016/j.jns.2015.07.001 pmid:26169158
CrossRef PubMed
39.↵
2. Ringstad G,
3. Vatnehol SA,
4. Eide PK
. Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain 2017;140:2691–705 doi:10.1093/brain/awx191 pmid:28969373
CrossRef PubMed

Received September 5, 2018.
Accepted after revision October 24, 2018.

View Abstract

In this issue

Download PDF

Email Article

Citation Tools

Purchase

Cited By...

More in this TOC Section

Show more ADULT BRAIN

[1] 1.↵

Mori E,
Ishikawa M,
Kato T, et al
; Japanese Society of Normal Pressure Hydrocephalus. Guidelines for management of idiopathic normal pressure hydrocephalus: second edition. Neurol Med Chir (Tokyo) 2012;52:775–809 doi:10.2176/nmc.52.775 pmid:23183074
CrossRef PubMed

[3] Mori E,

[4] Ishikawa M,

[5] Kato T, et al

[6] 2.↵

Relkin N,
Marmarou A,
Klinge P, et al
. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery 2005;57(3 Suppl):S4–16; discussion ii-v pmid:16160425
CrossRef PubMed

[8] Relkin N,

[9] Marmarou A,

[10] Klinge P, et al

[11] 3.↵

Blomsterwall E,
Svantesson U,
Carlsson U, et al
. Postural disturbance in patients with normal pressure hydrocephalus. Acta Neurol Scand 2000;102:284–91 doi:10.1034/j.1600-0404.2000.102005284.x pmid:11083504
CrossRef PubMed

[13] Blomsterwall E,

[14] Svantesson U,

[15] Carlsson U, et al

[16] 4.↵

Hellström P,
Klinge P,
Tans J, et al
. A new scale for assessment of severity and outcome in iNPH. Acta Neurol Scand 2012;126:229–37 doi:10.1111/j.1600-0404.2012.01677.x pmid:22587624
CrossRef PubMed

[18] Hellström P,

[19] Klinge P,

[20] Tans J, et al

[21] 5.↵

Agerskov S,
Hellström P,
Andrén K, et al
. The phenotype of idiopathic normal pressure hydrocephalus: a single center study of 429 patients. J Neurol Sci 2018;391:54–60 doi:10.1016/j.jns.2018.05.022 pmid:30103972
CrossRef PubMed

[23] Agerskov S,

[24] Hellström P,

[25] Andrén K, et al

[26] 6.↵

Adams RD,
Fisher CM,
Hakim S, et al
. Symptomatic occult hydrocephalus with normal cerebrospinal-fluid pressure: a treatable syndrome. N Engl J Med 1965;273:117–26 doi:10.1056/NEJM196507152730301 pmid:14303656
CrossRef PubMed

[28] Adams RD,

[29] Fisher CM,

[30] Hakim S, et al

[31] 7.↵

Kockum K,
Lilja-Lund O,
Larsson EM, et al
. The idiopathic normal-pressure hydrocephalus Radscale: a radiological scale for structured evaluation. Eur J Neurol 2018;25:569–76 doi:10.1111/ene.13555 pmid:29281156
CrossRef PubMed

[33] Kockum K,

[34] Lilja-Lund O,

[35] Larsson EM, et al

[36] 8.↵

Virhammar J,
Laurell K,
Cesarini KG, et al
. Preoperative prognostic value of MRI findings in 108 patients with idiopathic normal pressure hydrocephalus. AJNR Am J Neuroradiol 2014;35:2311–18 doi:10.3174/ajnr.A4046 pmid:25012669
Abstract/FREE Full Text

[38] Virhammar J,

[39] Laurell K,

[40] Cesarini KG, et al

[41] 9.↵

Wikkelsö C,
Andersson H,
Blomstrand C, et al
. Computed tomography of the brain in the diagnosis of and prognosis in normal pressure hydrocephalus. Neuroradiology 1989;31:160–65 doi:10.1007/BF00698846 pmid:2747894
CrossRef PubMed

[43] Wikkelsö C,

[44] Andersson H,

[45] Blomstrand C, et al

[46] 10.↵

Kazui H,
Mori E,
Ohkawa S, et al
. Predictors of the disappearance of triad symptoms in patients with idiopathic normal pressure hydrocephalus after shunt surgery. J Neurol Sci 2013;328:64–69 doi:10.1016/j.jns.2013.02.020 pmid:23510566
CrossRef PubMed

[48] Kazui H,

[49] Mori E,

[50] Ohkawa S, et al

[51] 11.↵

Halperin JJ,
Kurlan R,
Schwalb JM, et al
. Practice guideline: idiopathic normal pressure hydrocephalus—response to shunting and predictors of response: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 2015;85:2063–71 doi:10.1212/WNL.0000000000002193 pmid:26644048
Abstract/FREE Full Text

[53] Halperin JJ,

[54] Kurlan R,

[55] Schwalb JM, et al

[56] 12.↵

Craven CL,
Toma AK,
Mostafa T, et al
. The predictive value of DESH for shunt responsiveness in idiopathic normal pressure hydrocephalus. J Clin Neurosci 2016;34:294–98 doi:10.1016/j.jocn.2016.09.004 pmid:27692614
CrossRef PubMed

[58] Craven CL,

[59] Toma AK,

[60] Mostafa T, et al

[61] 13.↵

Hashimoto M,
Ishikawa M,
Mori E, et al
; Study of INPH on neurological improvement (SINPHONI). Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study. Cerebrospinal Fluid Res 2010;7:18 doi:10.1186/1743-8454-7-18 pmid:21040519
CrossRef PubMed

[63] Hashimoto M,

[64] Ishikawa M,

[65] Mori E, et al

[66] 14.↵

Garcia-Armengol R,
Domenech S,
Botella-Campos C, et al
. Comparison of elevated intracranial pressure pulse amplitude and disproportionately enlarged subarachnoid space (DESH) for prediction of surgical results in suspected idiopathic normal pressure hydrocephalus. Acta Neurochir (Wien) 2016;158:2207–13 doi:10.1007/s00701-016-2858-5 pmid:27349896
CrossRef PubMed

[68] Garcia-Armengol R,

[69] Domenech S,

[70] Botella-Campos C, et al

[71] 15.↵

Shinoda N,
Hirai O,
Hori S, et al
. Utility of MRI-based disproportionately enlarged subarachnoid space hydrocephalus scoring for predicting prognosis after surgery for idiopathic normal pressure hydrocephalus: clinical research. J Neurosurg 2017;127:1436–42 doi:10.3171/2016.9.JNS161080 pmid:28156249
CrossRef PubMed

[73] Shinoda N,

[74] Hirai O,

[75] Hori S, et al

[76] 16.↵

Virhammar J,
Laurell K,
Cesarini KG, et al
. The callosal angle measured on MRI as a predictor of outcome in idiopathic normal-pressure hydrocephalus. J Neurosurg 2014;120:178–84 doi:10.3171/2013.8.JNS13575 pmid:24074491
CrossRef PubMed

[78] Virhammar J,

[79] Laurell K,

[80] Cesarini KG, et al

[81] 17.↵

Steffen TM,
Hacker TA,
Mollinger L
. Age- and gender-related test performance in community-dwelling elderly people: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and gait speeds. Phys Ther 2002;82:128–37 doi:10.1093/ptj/82.2.128 pmid:11856064
Abstract/FREE Full Text

[83] Steffen TM,

[84] Hacker TA,

[85] Mollinger L

[86] 18.↵

Podsiadlo D,
Richardson S
. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991;39:142–48 doi:10.1111/j.1532-5415.1991.tb01616.x pmid:1991946
CrossRef PubMed

[88] Podsiadlo D,

[89] Richardson S

[90] 19.↵

Tullberg M,
Rosengren L,
Blomsterwall E, et al
. CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus. Neurology 1998;50:1122–27 doi:10.1212/WNL.50.4.1122 pmid:9566405
Abstract/FREE Full Text

[92] Tullberg M,

[93] Rosengren L,

[94] Blomsterwall E, et al

[95] 20.↵

Solana E,
Poca MA,
Sahuquillo J, et al
. Cognitive and motor improvement after retesting in normal-pressure hydrocephalus: a real change or merely a learning effect? J Neurosurg 2010;112:399–409 doi:10.3171/2009.4.JNS081664 pmid:19480539
CrossRef PubMed

[97] Solana E,

[98] Poca MA,

[99] Sahuquillo J, et al

[100] 21.↵

Ishii K,
Kanda T,
Harada A, et al
. Clinical impact of the callosal angle in the diagnosis of idiopathic normal pressure hydrocephalus. Eur Radiol 2008;18:2678–83 doi:10.1007/s00330-008-1044-4 pmid:18500524
CrossRef PubMed

[102] Ishii K,

[103] Kanda T,

[104] Harada A, et al

[105] 22.↵

Kitagaki H,
Mori E,
Ishii K, et al
. CSF spaces in idiopathic normal pressure hydrocephalus: morphology and volumetry. AJNR Am J Neuroradiol 1998;19:1277–84 pmid:9726467
Abstract/FREE Full Text

[107] Kitagaki H,

[108] Mori E,

[109] Ishii K, et al

[110] 23.↵

Algin O,
Hakyemez B,
Taskapilioglu O, et al
. Morphologic features and flow void phenomenon in normal pressure hydrocephalus and other dementias: are they really significant? Acad Radiol 2009;16:1373–80 doi:10.1016/j.acra.2009.06.010 pmid:19717316
CrossRef PubMed

[112] Algin O,

[113] Hakyemez B,

[114] Taskapilioglu O, et al

[115] 24.↵

Fazekas F,
Chawluk JB,
Alavi A, et al
. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351–56 doi:10.2214/ajr.149.2.351 pmid:3496763
CrossRef PubMed

[117] Fazekas F,

[118] Chawluk JB,

[119] Alavi A, et al

[120] 25.↵

Virhammar J,
Laurell K,
Cesarini KG, et al
. Increase in callosal angle and decrease in ventricular volume after shunt surgery in patients with idiopathic normal pressure hydrocephalus. J Neurosurg 2018 Feb 2:1–6. [Epub ahead of print] doi:10.3171/2017.8.JNS17547 pmid:29393749
CrossRef PubMed

[122] Virhammar J,

[123] Laurell K,

[124] Cesarini KG, et al

[125] 26.↵

Benedetto N,
Gambacciani C,
Aquila F, et al
. A new quantitative method to assess disproportionately enlarged subarachnoid space (DESH) in patients with possible idiopathic normal pressure hydrocephalus: the SILVER index. Clin Neurol Neurosurg 2017;158:27–32 doi:10.1016/j.clineuro.2017.04.015 pmid:28448824
CrossRef PubMed

[127] Benedetto N,

[128] Gambacciani C,

[129] Aquila F, et al

[130] 27.↵

Wilson JT,
Hareendran A,
Hendry A, et al
. Reliability of the modified Rankin Scale across multiple raters: benefits of a structured interview. Stroke 2005;36:777–81 doi:10.1161/01.STR.0000157596.13234.95 pmid:15718510
Abstract/FREE Full Text

[132] Wilson JT,

[133] Hareendran A,

[134] Hendry A, et al

[135] 28.↵

Ishikawa M,
Oowaki H,
Takezawa M, et al
. Disproportionately enlarged subarachnoid space hydrocephalus in idiopathic normal-pressure hydrocephalus and its implication in pathogenesis. Acta Neurochir Suppl 2016;122:287–90 doi:10.1007/978-3-319-22533-3_57 pmid:27165923
CrossRef PubMed

[137] Ishikawa M,

[138] Oowaki H,

[139] Takezawa M, et al

[140] 29.↵

Jurcoane A,
Keil F,
Szelenyi A, et al
. Directional diffusion of corticospinal tract supports therapy decisions in idiopathic normal-pressure hydrocephalus. Neuroradiology 2014;56:5–13 doi:10.1007/s00234-013-1289-8 pmid:24158631
CrossRef PubMed

[142] Jurcoane A,

[143] Keil F,

[144] Szelenyi A, et al

[145] 30.↵

Lee PH,
Yong SW,
Ahn YH, et al
. Correlation of midbrain diameter and gait disturbance in patients with idiopathic normal pressure hydrocephalus. J Neurol 2005;252:958–63 doi:10.1007/s00415-005-0791-2 pmid:15834647
CrossRef PubMed

[147] Lee PH,

[148] Yong SW,

[149] Ahn YH, et al

[150] 31.↵

Tullberg M,
Jensen C,
Ekholm S, et al
. Normal pressure hydrocephalus: vascular white matter changes on MR images must not exclude patients from shunt surgery. AJNR Am J Neuroradiol 2001;22:1665–73 pmid:11673159
Abstract/FREE Full Text

[152] Tullberg M,

[153] Jensen C,

[154] Ekholm S, et al

[155] 32.↵

Ziegelitz D,
Starck G,
Kristiansen D, et al
. Cerebral perfusion measured by dynamic susceptibility contrast MRI is reduced in patients with idiopathic normal pressure hydrocephalus. J Magn Reson Imaging 2014;39:1533–42 doi:10.1002/jmri.24292 pmid:24006249
CrossRef PubMed

[157] Ziegelitz D,

[158] Starck G,

[159] Kristiansen D, et al

[160] 33.↵

Ziegelitz D,
Arvidsson J,
Hellström P, et al
. In patients with idiopathic normal pressure hydrocephalus postoperative cerebral perfusion changes measured by dynamic susceptibility contrast magnetic resonance imaging correlate with clinical improvement. J Comput Assist Tomogr 2015;39:531–40 doi:10.1097/RCT.0000000000000254 pmid:25974719
CrossRef PubMed

[162] Ziegelitz D,

[163] Arvidsson J,

[164] Hellström P, et al

[165] 34.↵

Tullberg M,
Hellström P,
Piechnik SK, et al
. Impaired wakefulness is associated with reduced anterior cingulate CBF in patients with normal pressure hydrocephalus. Acta Neurol Scand 2004;110:322–30 doi:10.1111/j.1600-0404.2004.00325.x pmid:15476461
CrossRef PubMed

[167] Tullberg M,

[168] Hellström P,

[169] Piechnik SK, et al

[170] 35.↵

Klinge PM,
Brooks DJ,
Samii A, et al
. Correlates of local cerebral blood flow (CBF) in normal pressure hydrocephalus patients before and after shunting: a retrospective analysis of [(15)O]H(2)O PET-CBF studies in 65 patients. Clin Neurol Neurosurg 2008;110:369–75 doi:10.1016/j.clineuro.2007.12.019 pmid:18262344
CrossRef PubMed

[172] Klinge PM,

[173] Brooks DJ,

[174] Samii A, et al

[175] 36.↵

Tullberg M,
Ziegelitz D,
Ribbelin S, et al
. White matter diffusion is higher in Binswanger disease than in idiopathic normal pressure hydrocephalus. Acta Neurol Scand 2009;120:226–34 doi:10.1111/j.1600-0404.2009.01165.x pmid:19485951
CrossRef PubMed

[177] Tullberg M,

[178] Ziegelitz D,

[179] Ribbelin S, et al

[180] 37.↵

Jeppsson A,
Höltta M,
Zetterberg H, et al
. Amyloid mis-metabolism in idiopathic normal pressure hydrocephalus. Fluids Barriers CNS 2016;13:13 doi:10.1186/s12987-016-0037-y pmid:27472944
CrossRef PubMed

[182] Jeppsson A,

[183] Höltta M,

[184] Zetterberg H, et al

[185] 38.↵

Nakajima M,
Miyajima M,
Ogino I, et al
. Cerebrospinal fluid biomarkers for prognosis of long-term cognitive treatment outcomes in patients with idiopathic normal pressure hydrocephalus. J Neurol Sci 2015;357:88–95 doi:10.1016/j.jns.2015.07.001 pmid:26169158
CrossRef PubMed

[187] Nakajima M,

[188] Miyajima M,

[189] Ogino I, et al

[190] 39.↵

Ringstad G,
Vatnehol SA,
Eide PK
. Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain 2017;140:2691–705 doi:10.1093/brain/awx191 pmid:28969373
CrossRef PubMed

[192] Ringstad G,

[193] Vatnehol SA,

[194] Eide PK

Main menu

User menu

Search

American Journal of Neuroradiology

Absence of Disproportionately Enlarged Subarachnoid Space Hydrocephalus, a Sharp Callosal Angle, or Other Morphologic MRI Markers Should Not Be Used to Exclude Patients with Idiopathic Normal Pressure Hydrocephalus from Shunt Surgery

Abstract

ABBREVIATIONS:

Materials and Methods

Clinical Evaluation

Imaging

Statistics

Ethical Considerations

Results

Surgical Outcome

Preoperative MR Imaging Findings and Outcome

Correlations with Clinical Symptoms

Discussion

Strengths and Weaknesses

Conclusions

Footnotes

References

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

News and Updates

Resources

Opportunities

American Society of Neuroradiology

Main menu

User menu

Search

Absence of Disproportionately Enlarged Subarachnoid Space Hydrocephalus, a Sharp Callosal Angle, or Other Morphologic MRI Markers Should Not Be Used to Exclude Patients with Idiopathic Normal Pressure Hydrocephalus from Shunt Surgery

Abstract

ABBREVIATIONS:

Materials and Methods

Clinical Evaluation

Imaging

Statistics

Ethical Considerations

Results

Surgical Outcome

Preoperative MR Imaging Findings and Outcome

Correlations with Clinical Symptoms

Discussion

Strengths and Weaknesses

Conclusions

Footnotes

References

In this issue

Citation Manager Formats

Jump to section

Related Articles

Cited By...

More in this TOC Section

Similar Articles

News and Updates

Resources

Opportunities

American Society of Neuroradiology